Cigna GroupCI
Price$267.96Intrinsic value$341.0427% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $341.04median of 6 methods · middle span $280-$680based on filings through 30 Jun 2026
Market Price $267.96Price as of 1 Oct 2026
Margin of Safety +27.3%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.5% (near-term consensus, capped) · years 2–5: 8.0%/yr (balance of the path).7.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 67.9%Yr 77.8%Yr 87.7%Yr 97.6%Yr 107.5%
8.0% → 7.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.1%Yr 126.6%Yr 136.2%Yr 145.7%Yr 155.3%Yr 164.8%Yr 174.4%Yr 183.9%Yr 193.5%Yr 203.0%
7.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)8.7%
Discount rate (cost of equity) 7.4%
Volatility vs market (adjusted beta)0.54

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetCigna GroupCIHealth Care
Valuation
P/E11.1×
P/S0.3×
P/B1.7×
EV / Revenue0.3×
EV / EBITDA—
Profitability
Gross margin—
Operating margin3.5%
Net margin2.3%
FCF margin—
Returns
ROE15.1%
ROA4.1%
ROIC9.8%
Growth
Revenue growth (YoY)14.3%
5-yr fwd EPS growth7.5%
Financial strength
Debt / Equity0.68×
Current ratio0.85×
Altman Z-Score2.8
Interest coverage—
Dividend yield1.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.